Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
Clinical trial NCT01377389 · TERMINATED
Trial details
- NCT number
- NCT01377389
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-17
- Primary completion
- 2017-04-07
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.